Volume 13, Number 2—February 2007
Neutralizing Antibodies after Infection with Dengue 1 Virus
|Serotype||Strain||Passage no.*||Place and year of isolation|
|DENV-1†||Angola||4PC6/36 1PVero 1PC6/36||Angola, 1988|
|DENV-2‡||A15/81||4PMB 4PC6/36||Cuba, 1981|
|DENV-2†‡||I348600||4P C6/36||Colombia, 1986|
|DENV-3||116/00||3P C6/36||Cuba, 2000|
|DENV-4†||Dominica||7P C6/36||Dominica, 1981|
**P, passage; C6/36, Aedes albopictus cell line; Vero, green monkey kidney cell line; MB, mouse brain.
†DENV, dengue virus; received from Robert Shope, University of Texas Medical Branch, Galveston, Texas, USA.
‡DENV-2, A15/81 strain (Asian genotype), DENV 2, I348600 (American genotype).
- Page created: June 29, 2010
- Page last updated: June 29, 2010
- Page last reviewed: June 29, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)